Shaanxi Yuanguang Biological Innovation material Co..Ltd.-Dedicated to the application of biocomposite medical high-tech materials and the research and development of peptide drugs

Farlight Bio

Dedicated to the application of bio-composite medical high-tech materials and the research and development of peptide-based drugs.

Dedicated to the application of bio composite medical high-tech materials and the research and development of peptide drugs

PRODUCTS & SERVICES

Short peptide synthesis

Cosmetic raw materials

Contract Manufacturing Services

Exploring Optimization of Raw Material Synthesis Processes

Screening and Synthesis of Food Additives

R&D CENTER

National-level

Polypeptide and Biomedical New Material Application R&D Public Service Platform

The platform brings together a team of experienced researchers specializing in peptides and small molecules, led by a group of professors under the guidance of academicians. In addition, the platform is equipped with specialized laboratories, including a peptide laboratory, a protein and peptide analysis laboratory, a microbiology testing laboratory, and a bioluminescence research laboratory. It has established a comprehensive quality research system that complies with regulatory standards, providing partners with one-stop services—from raw materials to finished products.

PRODUCTS CASE

Acetyl Hexapeptide-8 (Hexapeptide)

Other peptide research directions

Can be used in a variety of anti-aging personal care products.
Eye care: Effectively reduces eye wrinkles and crow's feet around the corners of the eyes.
Facial care: Effectively reduces forehead wrinkles caused by muscle contractions.

Cyclo(his-pro)
Angiotensin 1-7 (Ang1-7)
Body Protection Peptide (BPC-157 Peptide) and others

R&D TEAM

A doctoral-level R&D team of more than 30 members

Yuanguang Bio boasts a research and development team of over 30 members, all holding doctoral degrees. The team members come from pharmaceutical companies and have many years of experience in drug development.

Years of experience in peptide synthesis services

The management team has extensive experience in innovative drug R&D and technical services, as well as many years of expertise in peptide synthesis services, helping to facilitate the preparation of highly challenging peptides and the development of related manufacturing processes.

Over 10 years of experience in peptide drug process development

The team has over 10 years of experience in peptide drug process development, ensuring the process is economically viable, robust, and reproducible.

LATEST NEWS

More information

Industry Trends

Reading Notes on “I Offer Peptides to You”—Skin Penetrating Peptides (SKPs): Enhancing the Transdermal Penetration of Pharmaceutical and Cosmetic Ingredients to Achieve the Goal of Transdermal Drug Delivery

Skin-penetrating peptides (SKPs) are gradually emerging as a highly promising class of enhancers capable of facilitating the delivery of macromolecular substances across the skin.

Industry Trends

“Blue” Confidant: The Blue Diamond of the Skincare World—Copper Peptides

In the skincare world, where ingredient-focused trends reign supreme, you’ve surely heard of “C in the morning, A at night,” exfoliated with acids, and used hyaluronic acid. But did you know that among the myriad active ingredients, there’s a mysterious yet luxurious shade of blue waiting to be discovered? That’s none other than copper peptide—a compound often hailed as the “blue diamond of the skincare world.”

Industry Trends

Reading Notes on “I Offer Peptides to You”—Fluorescein Amine Is a Termination Agent in Solid-Phase Peptide Synthesis

Fluorescein amine has been shown to be an excellent terminating agent used in solid-phase peptide synthesis to block unreacted amino groups. A comparison with the efficiency of acetylation termination reveals that products generated by the fluorescein amine method are evaluated as superior in peptide analysis, dansyl-based N-terminal assays, and bioassays. Moreover, the fragments terminated with fluorescein amine are converted into non-fluorescent spiro-lactones during the deprotection step. These spiro-lactones exhibit stability under subsequent solid-phase reaction conditions and can be readily removed from the target peptide.

Address: Room 10101, Building 7, No. 2 West Qinling Avenue, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City

Phone: +8619909225837

Email: 19909225837@163.com

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.